HCG and Accenture collaborate to advance cancer research, Health News, ET HealthWorld
Bengaluru: HealthCare Global Enterprises Limited (HCG), one of the cancer care networks in India, is collaborating with Accenture (NYSE: ACN) to accelerate cancer research and care through the use of advanced AI, including generative AI and deep learning on multi-dimensional and multi-omic patient data.
Accenture will apply technologies such as image analysis, informatics, and algorithms to study data from cancer patients. This will include examining molecular changes that could influence treatment approaches. The program, which is the first of its kind in South Asia, will also explore new drug targets, treatment methods, and biomarkers to better understand different cancer types.
Additionally, the initiative aims to enhance the understanding of various cancers, including their development, symptoms, and origins, to enable new treatment algorithms for precision medicine and advance the quality of therapy and care. It will showcase data-driven clinical practice and enhance the overall efficiency of patient care by applying AI, generative AI, cloud, machine learning, and quantum computing, among others. The collaboration is currently focused on identifying molecular signatures for the prognosis and response to therapy for lung adenocarcinoma, and head and neck cancers, which will then be extended to other cancer types.Dr. B. S. Ajaikumar, Executive Chairman of HealthCare Global Enterprises Limited, said, “Today, optimizing cancer care necessarily calls for tech-driven advancements in research and academics, especially for ensuring seamless, error-free data collection and streaming. Given the heterogenicity of tumor genomics and other forms of omics, AI has become integral to precise, personalized medical advancements. AI-powered innovation has activated established drugs in certain tumors, which was not the case previously. Accenture’s deep expertise in technology and analytics, leveraging AI modeling, will help us enhance our research aimed at developing patient-centric therapies with lasting outcomes.”Senthil Ramani, Global Lead of Data and AI at Accenture, said, “Next-gen computing, including generative AI, combined with deep biological and clinical expertise, can play a pivotal role in cancer research and care, addressing needs of patients and benefiting the global healthcare industry at large.”
Visit: Valley Vision News
